How Will Deckers' Stock React To Its Upcoming Earnings?
Photo byDeckers Outdoor Corp (NYSE: DECK) is set to announce its fiscal fourth-quarter earnings (March year) on Thursday, May 22, 2025, with analysts predicting earnings of 60 cents per share and revenue of $1 billion. This would indicate a 28% decline in earnings year-over-year, along with a 4% sales growth compared to last year's figures of 83 cents per share and $960 million in revenue. Historically, DECK stock has risen 61% of the time after earnings announcements, with a median one-day increase of 9.0% and a maximum recorded rise of 19%.
Deckers primarily owns the Ugg and Hoka shoe brands, which represent its two largest and most important sources of revenue, accounting for approximately 68% and 29% of total sales, respectively. In the third quarter of fiscal 2025, both brands showed strong consumer interest, with Ugg achieving a 16% increase in sales while Hoka outperformed with a 24% gain. Despite having a relatively narrow brand portfolio, the company's key products continue to resonate well with consumers. However, investors might currently be concerned about tariff-related issues, as a substantial part of Deckers' footwear manufacturing occurs in Asia. The company currently holds a market capitalization of $19 Bil. Revenue for the past twelve months was $4.9 Bil, and it was operationally profitable with $1.1 Bil in operating profits and $942 Mil in net income.
For event-driven traders, historical trends may provide an advantage, whether by positioning before earnings releases or responding to post-release actions. This said, for those wanting upside potential with lower volatility than individual stocks, the Trefis High Quality portfolio offers an alternative, having surpassed the S&P 500 and achieving returns over 91% since its launch. See earnings reaction history of all stocks.
Here are some insights on one-day (1D) post-earnings returns:
Further data on the observed 5-Day (5D) and 21-Day (21D) returns following earnings are summarized along with the statistics in the table below.
DECK Post Earnings Returns
A relatively less risky approach (though not useful if the correlation is weak) is to analyze the correlation between short-term and medium-term returns after earnings, identifying a pair with the highest correlation, and executing the suitable trade. For instance, if 1D and 5D show the strongest correlation, a trader could adopt a 'long' position for the next 5 days if the 1D post-earnings return is positive. Below is some correlation data based on 5-year and 3-year (more recent) history. Note that the correlation 1D_5D indicates the correlation between 1D post-earnings returns and the following 5D returns.
DECK Correlation Between 1D, 5D and 21D Historical Returns
Discover more about Trefis RV strategy that has outperformed its all-cap stocks benchmark (the combination of the S&P 500, S&P mid-cap, and Russell 2000), yielding strong returns for investors.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
After Hitting All-Time Highs This Year, Is Berkshire Hathaway a Buy Today?
Berkshire Hathaway is run by none other than Warren Buffett, arguably the greatest investor of our time. Berkshire's stock has outperformed the S&P 500 this year and hit all-time highs. Investors seem to like the company's diversity of businesses and its management, and view the stock as a flight to safety. 10 stocks we like better than Berkshire Hathaway › Once the Trump administration began to implement sweeping tariffs against major trading partners of the U.S. in April, investors, sensing a significant disruption in the market, ditched U.S. risk assets and ran for cover. They piled into cash, gold, and assets they believed could provide a port in the storm. One of those happened to be Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), one of the largest conglomerates in the world, run by arguably the world's best investor, Warren Buffett. Berkshire's stock was up nearly 10% (as of June 4), compared to the broader benchmark S&P 500's roughly 2% gain. Berkshire's stock also hit all-time highs earlier this year. Is the stock still a buy today? Aside from Buffett and his strong team of investing lieutenants and managers, one thing investors seem to like about Berkshire is the diversity of businesses under the large conglomerate's umbrella. Berkshire not only operates a massive stock portfolio, but also a large insurance business as the owner of Geico. The company also owns a slate of energy assets, the Burlington North Santa Fe Railroad, and a mortgage business, among others. It might be difficult for some of these sectors to operate alone, but together they provide diversity and have turned Berkshire into a juggernaut that generated over $89.5 billion of earnings in 2024. It also had $47.4 billion of operating earnings, which Buffett believes is a better metric for the company because it strips out volatile unrealized capital gains and losses. Another reason investors view Berkshire as a flight to safety is because of the company's massive cash hoard. Combined, Berkshire's cash, cash equivalents, short-term U.S. Treasury investments, and investments in fixed-maturity securities totaled an incredible $357 billion. Berkshire now reportedly owns about 5% of the short-term Treasury bill market. The massive pile of cash gives Berkshire a huge margin of safety -- and also a war chest, should opportunities arise in the market that Berkshire finds compelling. Now, after a strong run, it's always important to look at a stock's valuation. One way investors like to value Berkshire is on a price-to-tangible book value (TBV) basis, which is a frequent way investors value bank and insurance stocks. As you can see above, Berkshire's stock recently traded slightly under two times TBV. That's down from highs the stock reached earlier this year, but also above the company's five-year average. While Berkshire's stock does look a bit expensive right now, I still think long-term-oriented investors will be served well by owning it. For one, Buffett and his team have built Berkshire to last, meaning it can perform well through the entirety of the economic cycle, including the tougher parts. Berkshire's equities portfolio has exposure to growth stocks like tech and artificial intelligence, but management are also clearly big believers in oil and gas, which they may view as a finite resource. Not only does the company own and operate energy businesses, but Berkshire has major stakes in large domestic oil and gas producers like Occidental Petroleum and Chevron. These stocks should perform well if the price of oil, which trades in the low $60s per barrel, eventually rises. Investors may be concerned over the fact that Buffett, who is 94 years old, is preparing to retire at the end of 2025 after over six decades on the job. No one will ever be able to replace the Oracle of Omaha, but incoming CEO Greg Abel is more than capable. Without the Buffett brand, I think Berkshire may also try to entice investors by returning more capital to shareholders through stock repurchases and perhaps even a dividend, which Berkshire has never paid before. So even with the departure of Buffett, who will stay on as chair of the company's board of directors, it's not all doom and gloom. There is still much more for investors to look forward to. Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Berkshire Hathaway wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Bram Berkowitz has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway and Chevron. The Motley Fool recommends Occidental Petroleum. The Motley Fool has a disclosure policy. After Hitting All-Time Highs This Year, Is Berkshire Hathaway a Buy Today? was originally published by The Motley Fool Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
Newsmax Stock Is Set to Join the U.S. Small-Cap Russell 2000 Index in Less Than a Month. Time to Buy?
Newsmax stock has steadily declined since a brief surge after its IPO. The stock trades at a premium valuation. It's delivering solid growth, but traditional media has been a challenging industry for investors. 10 stocks we like better than Newsmax › Newsmax (NYSE: NMAX) has only been a publicly traded company for a couple of months, but it's stuffed a lot of excitement into a short period of time. After pricing its shares at $10 on March 31, the stock skyrocketed to $233 over a two-day trading frenzy before plunging back down to earth. A limited float, high demand, interest in a conservative media brand, and the meme stock effect all combined to send the stock briefly soaring. Since then, Newsmax has gradually declined, closing at $18.09 a share on June 4, though that's still up more than 80% from its IPO price. However, Newsmax shareholders did get some good news recently. The stock is set to join the small-cap Russell 2000 index at the end of the month, meaning that exchange-traded funds (ETFs) that track the index will have to buy shares of Newsmax, which should help boost the stock price. With Newsmax getting some recognition from the best-known small-cap index, it's a good time to ask if the stock is worth buying. Here's what you need to know about Newsmax. IPOs for traditional media companies aren't particularly common in the current era, but Newsmax seemed to see an opportunity to capitalize on interest in conservative media brands in the wake of President Donald Trump's election, and it has so far paid off. In addition to the core broadcasting business, which includes two linear cable channels and a streaming channel, Newsmax also has a digital business, Humanix Publishing, that includes a print and e-book publishing house; Medix Health, which sells 22 nutraceutical products aimed at Newsmax's demographic; an advertising and media strategy business; and an insurance agency, Crown Atlantic Insurance, that primarily sells life insurance and retirement solutions like annuities. As a business, Newsmax's growth has been surprisingly strong; total revenue rose 26% last year to $171 million. Advertising revenue, which makes up the majority of its revenue, was essentially flat, but revenue from affiliate fees surged due to new contractual relationships that began in late 2023. On an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) basis, it flipped a $10.4 million loss in 2023 to a $10.3 million profit in 2024, due to strong performance in the broadcasting division. Newsmax is now the fourth-highest-rated cable news channel in the U.S., and had 33.6 million viewers in the first quarter. Revenue rose 12% in the first quarter to $45.3 million. Newsmax aims to grow in a number of ways, including expanding the Newsmax audience, growing its premium content to build its subscription business, and expanding its television and digital offerings. Even with some impressive audience growth numbers, including a 50% jump in viewers in the first quarter, traditional television media is a tough sell in this day and age, and Newsmax seems destined to fight an uphill battle even if the political climate remains favorable. For example, viewership could have jumped in the first quarter due to the inauguration or interest in Trump. Investors shouldn't assume that that growth rate is sustainable over the long term. The company's lack of a generally accepted accounting principles (GAAP) profit is also concerning; it lost $72.2 million last year, though that was due in part to a one-time net costs increase of $53 million related to legal fees for the settlement of the Smartmatic lawsuit. In the first quarter, it lost $17.2 million. Additionally, the timing of the IPO, when there was considerable interest in Trump and related businesses, won't help the business over the long term. Overall, Newsmax could be successful despite the larger media industry headwinds, but the stock isn't even an attractive value right now, trading at a price-to-sales ratio of 14. At a better valuation and with a GAAP profit, Newsmax might be worth taking a small position in. While gaining admission into the Russell 2000 is a step in the right direction, it's not enough to make the stock a buy. Before you buy stock in Newsmax, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Newsmax wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Newsmax Stock Is Set to Join the U.S. Small-Cap Russell 2000 Index in Less Than a Month. Time to Buy? was originally published by The Motley Fool
Yahoo
2 hours ago
- Yahoo
Billionaire Stanley Druckenmiller Has Unloaded Shares of Last Year's 2 Top Performing AI Stocks and Is Piling Into a Growth Stock That Has Climbed 150% in 3 Years
Druckenmiller has a stunning investment track record, regularly delivering double-digit percentage annual returns with no money-losing years. In recent times, the billionaire has benefited from investments in some of today's top growth stocks. 10 stocks we like better than Eli Lilly › You don't have to be a billionaire to invest like one -- and reap the rewards. Any of us can look at the moves made by the world's most successful investors and follow those that also fit into our investment strategy. Billionaire fund managers have proven their strengths as investors over time, making them excellent guides for novices on the wealth-building path. With that in mind, let's consider the recent moves made by Stanley Druckenmiller, founder of the Duquesne Family Office. Over the past few quarters, he closed his position in last year's two top-performing S&P 500 and Dow Jones Industrial Average artificial intelligence (AI) stocks, and just recently, he increased his position in a growth stock that has soared by 150% over the past three years. Could taking those cues be a smart move for you? So, first, a bit about why Druckenmiller is a billionaire worth watching and potentially following. He founded Duquesne Capital Management in the early 1980s and ran the fund for 30 years. Over that time period, he delivered a truly remarkable annualized average return of 30% -- and importantly, never had a money-losing year. Since then, he has shifted his focus to his family office, where he invests in stocks across industries and oversees $3 billion in securities. Now, let's consider his recent moves, starting with a major one. In the third quarter, Druckenmiller closed out his position in AI chip market leader Nvidia (NASDAQ: NVDA), a company that climbed a bit further from there, becoming the Dow Jones Industrial Average component that delivered the biggest annual gain of 2024. The investor originally bought Nvidia shares in the fourth quarter of 2022, and from the end of that quarter through the end of last year's third quarter, they climbed by more than 700%. So this clearly was a winning investment for Druckenmiller, though in a Bloomberg interview, he expressed regret about the timing of the sale, and said he would consider buying Nvidia stock again at the right price. Druckenmiller's second big sale came in the first quarter of this year: He closed out his position in Palantir Technologies (NASDAQ: PLTR), a stock he bought a year earlier. Last year, the AI software company generated the biggest gain in the S&P 500, climbing by 340%. Meanwhile, Druckenmiller increased his position in another growth stock: pharma giant Eli Lilly (NYSE: LLY), which in recent quarters has delivered double-digit percentage revenue gains. That growth came largely thanks to its position in a high-growth market with solid long-term potential: weight loss drugs. Druckenmiller increased his Lilly holding by 52% in the first quarter and now owns 94,830 shares worth about $73 million as of the close of trading Friday. Lilly represents nearly 2.6% of the billionaire's portfolio, up from about 1.3% in the previous quarter. He initially bought the stock in 2024's fourth quarter, so he clearly is building a position in it, and sees opportunity for growth ahead. Lilly sells a wide variety of medicines, but investors have focused on its GLP-1 agonist tirzepatide in recent quarters -- and for good reason. Tirzepatide is sold under the name Mounjaro for type 2 diabetes and Zepbound for weight loss, and both drugs are generating blockbuster revenues. Doctors have prescribed either one for weight loss, and demand has been so high that last year, both were on the Food and Drug Administration's shortage list. These drugs should continue to generate sales growth due to ongoing high demand; analysts at Goldman Sachs forecast that the weight loss drug market will be about $95 billion annually by 2030. One more element may supercharge Lilly's growth in this market. Mounjaro, Zepbound, and the competing GLP-1 drugs on the market today all must be administered via injection, but Lilly has been developing a new weight loss candidate in pill form. Phase 3 trials have produced strong data for the pill, dubbed orforglipron, and Lilly says it will apply for regulatory review in the weight loss indication by the end of this year. The convenience of a weight loss pill that is as effective as the injectables could help orforglipron (and Lilly) take a leading share of the market in the years to come. So the drugmaker's growth may be far from over. Should you follow Druckenmiller's lead, exit Nvidia and Palantir (if you own them), and get in on Lilly shares? All three of these companies are leaders in exciting growth markets and could gain over the long term, so your decisions should depend on your investment strategy. If you're a cautious investor and like passive income, Eli Lilly is a great choice to own because, while it does offer share price growth potential, it also offers the safety and steady dividends of an established pharma player. If you're an aggressive investor, though, you may want to favor the AI story and continue along with Nvidia and/or Palantir over the long term. Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia and Palantir Technologies. The Motley Fool has a disclosure policy. Billionaire Stanley Druckenmiller Has Unloaded Shares of Last Year's 2 Top Performing AI Stocks and Is Piling Into a Growth Stock That Has Climbed 150% in 3 Years was originally published by The Motley Fool
